A tumour suppressor methylation panel (APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P16, P21 and TIMP3) showed 91.7% sensitivity in distinguishing BC patients from normal individuals41. This evidence concerns the gene ESR2 and breast cancer.